Meeting News

Meeting News

HPSCs and Hematopoiesis: From Development to Stem Cell Therapies

As part of this year’s Scientific Program, Gay M. Crooks, MBBS, and Christopher M. Sturgeon, PhD, are co-chairing a session that will review human...

The Future of Iron Therapeutics

Therapies for disorders of iron metabolism are rapidly progressing beyond venesection, chelation, and nutritional iron supplementation. Recent research elucidating the molecular and structural biology...

Blood and Beyond: Irrigating the Clinical Desert

This year’s Blood and Beyond session will be hosted by Nancy Berliner, MD, Editor-in-Chief of Blood, and will showcase the work of Paul Farmer, MD,...

The Hematology Laboratory of the Future

Recent and profound advances in artificial intelligence (AI), data science, and computer vision are having a profound impact on many industries, including medicine. The clinical...

Covering the Full Breadth and Depth of Hematology

Interview with Education Program co-chairs Alison Loren, MD, and Anita Rajasekhar, MD What were your goals in crafting this year’s education program? Dr. Loren: Dr. Rajasekhar...

Are New Clinical Trial Designs Effective?

Among the goals of the ASH Subcommittee on Clinical Trials is to increase accrual to clinical trials within the hematology space, ensure diversity among...

The Role of Race in Biomedical Research

This year’s program includes a “Special Scientific Session on Race and Science” that will feature presentations on the construct of race and the implications...

A Cutting-Edge Program to Contextualize COVID-19

Interview with Scientific Program Co-Chairs Benjamin Kile, PhD, and Omar Abdel-Wahab, MD As co-chairs, what were your goals in creating this year’s Scientific Program? Dr. Kile:...
On location

Researchers Validate Burkitt Lymphoma Prognostic Index

Researchers have created a prognostic index specific to Burkitt lymphoma (BL) that will allow for simplified stratification and comparison of risk distribution in geographically...
On location

Thiotepa-Containing Conditioning Regimens Improve Survival Outcomes in Patients With PCNSL

Thiotepa-containing conditioning regimens, including thiotepa/busulfan/cyclophosphamide (TBC) and thiotepa/carmustine (TT-BCNU), were associated with favorable survival outcomes in patients with primary diffuse large B-cell lymphoma of...
Advertisement

Current Issue

December 2021 Volume 7 Issue 15

This issue explores doctor deserts, celebrates the 50th anniversary of the National Cancer Act, and more.

Block title